{"entity":{"type":"insider","cik":"0001768987","url":"/insider/0001768987","json_url":"/insider/0001768987.json","name":"Flagship VentureLabs V Manager LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":2,"first":"2019-03-06","last":"2021-08-05","span_basis":"filed_date"},"name_variants":[{"name":"Flagship VentureLabs V Manager LLC","source":"filing","n_filings":2,"first_seen":"2019-03-06","last_seen":"2021-08-05"}],"transactions":[{"id":5037920,"accession":"0000899243-21-031797","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-21-031797","line_url":"/filing/0000899243-21-031797#line-9","is_derivative":false,"issuer_cik":"0001400240","issuer_name":"Omega Therapeutics, Inc.","issuer_ticker":"OMGA","issuer_name_source":null,"issuer_url":"/issuer/0001400240","owner_cik":null,"owner_name":"Flagship V VentureLabs Rx Fund, L.P.; Flagship VentureLabs V Manager LLC; Flagship VentureLabs V LLC; Flagship Pioneering Inc.; Flagship Ventures Fund V, L.P.; Flagship Ventures Fund V General Partner LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":661764.0,"shares_display":"661,764","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":11249988.0,"total_display":"11,249,988.00","shares_owned_after":5514707.0,"shares_owned_after_display":"5,514,707","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-05","scope":"insider"},{"id":5037917,"accession":"0000899243-21-031797","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-21-031797","line_url":"/filing/0000899243-21-031797#line-8","is_derivative":false,"issuer_cik":"0001400240","issuer_name":"Omega Therapeutics, Inc.","issuer_ticker":"OMGA","issuer_name_source":null,"issuer_url":"/issuer/0001400240","owner_cik":null,"owner_name":"Flagship V VentureLabs Rx Fund, L.P.; Flagship VentureLabs V Manager LLC; Flagship VentureLabs V LLC; Flagship Pioneering Inc.; Flagship Ventures Fund V, L.P.; Flagship Ventures Fund V General Partner LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":294117.0,"shares_display":"294,117","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":4999989.0,"total_display":"4,999,989.00","shares_owned_after":1617646.0,"shares_owned_after_display":"1,617,646","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-05","scope":"insider"},{"id":5037910,"accession":"0000899243-21-031797","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-21-031797","line_url":"/filing/0000899243-21-031797#line-7","is_derivative":false,"issuer_cik":"0001400240","issuer_name":"Omega Therapeutics, Inc.","issuer_ticker":"OMGA","issuer_name_source":null,"issuer_url":"/issuer/0001400240","owner_cik":null,"owner_name":"Flagship V VentureLabs Rx Fund, L.P.; Flagship VentureLabs V Manager LLC; Flagship VentureLabs V LLC; Flagship Pioneering Inc.; Flagship Ventures Fund V, L.P.; Flagship Ventures Fund V General Partner LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":220588.0,"shares_display":"220,588","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":3749996.0,"total_display":"3,749,996.00","shares_owned_after":8617413.0,"shares_owned_after_display":"8,617,413","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-05","scope":"insider"},{"id":8436925,"accession":"0000899243-19-006455","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-19-006455","line_url":"/filing/0000899243-19-006455#line-12","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Kaleido Biosciences, Inc.","issuer_ticker":"KLDO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Pioneering Inc.; Flagship VentureLabs V LLC; Flagship Ventures Fund V General Partner LLC; Nutritional Health Disruptive Innovation Fund, L.P.; Flagship Ventures Fund V, L.P.; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I, L.P.; Flagship VentureLabs V Manager LLC; Nutritional Health Side Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":333333.0,"shares_display":"333,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","shares_owned_after":6560523.0,"shares_owned_after_display":"6,560,523","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-06","scope":"insider"},{"id":8436921,"accession":"0000899243-19-006455","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-19-006455","line_url":"/filing/0000899243-19-006455#line-11","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Kaleido Biosciences, Inc.","issuer_ticker":"KLDO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Pioneering Inc.; Flagship VentureLabs V LLC; Flagship Ventures Fund V General Partner LLC; Nutritional Health Disruptive Innovation Fund, L.P.; Flagship Ventures Fund V, L.P.; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I, L.P.; Flagship VentureLabs V Manager LLC; Nutritional Health Side Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":333333.0,"shares_display":"333,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","shares_owned_after":2244305.0,"shares_owned_after_display":"2,244,305","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-06","scope":"insider"},{"id":8436917,"accession":"0000899243-19-006455","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000899243-19-006455","line_url":"/filing/0000899243-19-006455#line-10","is_derivative":false,"issuer_cik":"0001222012","issuer_name":"Kaleido Biosciences, Inc.","issuer_ticker":"KLDO","issuer_name_source":null,"issuer_url":"/issuer/0001222012","owner_cik":null,"owner_name":"Flagship Ventures Opportunities Fund I General Partner LLC; Flagship Pioneering Inc.; Flagship VentureLabs V LLC; Flagship Ventures Fund V General Partner LLC; Nutritional Health Disruptive Innovation Fund, L.P.; Flagship Ventures Fund V, L.P.; AFEYAN NOUBAR; Flagship Ventures Opportunities Fund I, L.P.; Flagship VentureLabs V Manager LLC; Nutritional Health Side Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":266667.0,"shares_display":"266,667","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":4000005.0,"total_display":"4,000,005.00","shares_owned_after":2560096.0,"shares_owned_after_display":"2,560,096","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-06","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001850838","name":"Omega Therapeutics, Inc.","url":"/issuer/0001850838","role":"Ten percent owner","n_filings":1,"first_seen":"2021-08-05","last_seen":"2021-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001751299","name":"Kaleido Biosciences, Inc.","url":"/issuer/0001751299","role":"Ten percent owner","n_filings":1,"first_seen":"2019-03-06","last_seen":"2019-03-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001768987","retrieved_at":"2026-08-22T03:46:49+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}